Unknown

Dataset Information

0

Admission lactate level and the GRACE 2.0 score are independent and additive predictors of 30-day mortality of STEMI patients treated with primary PCI-Results of a real-world registry.


ABSTRACT:

Background

In many of the risk estimation algorithms for patients with ST-elevation myocardial infarction (STEMI), heart rate and systolic blood pressure are key predictors. Yet, these parameters may also be altered by the applied medical treatment / circulatory support without concomitant improvement in microcirculation. Therefore, we aimed to investigate whether venous lactate level, a well-known marker of microcirculatory failure, may have an added prognostic value on top of the conventional variables of the "Global Registry of Acute Coronary Events" (GRACE) 2.0 model for predicting 30-day all-cause mortality of STEMI patients treated with primary percutaneous coronary intervention (PCI).

Methods

In a prospective single-center registry study conducted from May 2020 through April 2021, we analyzed data of 323 cases. Venous blood gas analysis was performed in all patients at admission. Nested logistic regression models were built using the GRACE 2.0 score alone (base model) and with the addition of venous lactate level (expanded model) with 30-day all-cause mortality as primary outcome measure. Difference in model performance was analyzed by the likelihood ratio (LR) test and the integrated discrimination improvement (IDI). Independence of the predictors was evaluated by the variance inflation factor (VIF). Discrimination and calibration was characterized by the c-statistic and calibration intercept / slope, respectively.

Results

Addition of lactate level to the GRACE 2.0 score improved the predictions of 30-day mortality significantly as assessed by both LR test (LR Chi-square = 8.7967, p = 0.0030) and IDI (IDI = 0.0685, p = 0.0402), suggesting that the expanded model may have better predictive ability than the GRACE 2.0 score. Furthermore, the VIF was 1.1203, indicating that the measured lactate values were independent of the calculated GRACE 2.0 scores.

Conclusions

Our results suggest that admission venous lactate level and the GRACE 2.0 score may be independent and additive predictors of 30-day all-cause mortality of STEMI patients treated with primary PCI.

SUBMITTER: Szabo D 

PROVIDER: S-EPMC9668119 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

Admission lactate level and the GRACE 2.0 score are independent and additive predictors of 30-day mortality of STEMI patients treated with primary PCI-Results of a real-world registry.

Szabo Dominika D   Szabo Andras A   Magyar Levente L   Banhegyi Gyongyver G   Kugler Szilvia S   Pinter Anita A   Juhasz Vencel V   Ruppert Mihaly M   Olah Attila A   Ruzsa Zoltan Z   Edes Istvan Ferenc IF   Szekely Andrea A   Becker David D   Merkely Bela B   Hizoh Istvan I  

PloS one 20221116 11


<h4>Background</h4>In many of the risk estimation algorithms for patients with ST-elevation myocardial infarction (STEMI), heart rate and systolic blood pressure are key predictors. Yet, these parameters may also be altered by the applied medical treatment / circulatory support without concomitant improvement in microcirculation. Therefore, we aimed to investigate whether venous lactate level, a well-known marker of microcirculatory failure, may have an added prognostic value on top of the conve  ...[more]

Similar Datasets

| S-EPMC10059932 | biostudies-literature
| S-EPMC9918240 | biostudies-literature
| S-EPMC7988313 | biostudies-literature
| S-EPMC7753646 | biostudies-literature
| S-EPMC8521583 | biostudies-literature
| S-EPMC9207087 | biostudies-literature
| S-EPMC11012851 | biostudies-literature
| S-EPMC6203327 | biostudies-literature
| S-EPMC7665729 | biostudies-literature
| S-EPMC11255126 | biostudies-literature